The impact of pharmaceutical services in community and ambulatory care settings: Evidence and recommendations for future research

Annals of Pharmacotherapy

Volumn 33, Issue 12, 1999, Pages 1336-1355

  Singhal, Puneet K ^a,b   Raisch, Dennis W ^c   Gupchup, Gireesh V ^c  

^a UNIVERSITY OF NEW MEXICO   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

^c Dept Vet Aff Coop Studs P ^*

Author keywords

Ambulatory care; Community pharmacy; Pharmaceutical services

Indexed keywords

AMBULATORY CARE; ARTICLE; CLINICAL FEATURE; COMMUNITY CARE; CONTROLLED STUDY; ECONOMIC ASPECT; HEALTH SERVICE; HUMAN; MAJOR CLINICAL STUDY; PATIENT CARE; PHARMACY; PRIORITY JOURNAL; RESEARCH;

EID: 0033395767     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.18440     Document Type: Article

References (111)

1. Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm 1990;47:533-43.
2. Maine LL, Pathak DS. Measuring outcomes in contemporary pharmacy practice. In: Escovitz A. Pathak DS, eds. Health outcomes and pharmaceutical care: measurements, applications, and initiatives. New York: The Haworth Press, Inc., 1996:65-79.
3. Strand LM, Cipolle RJ, Morley PC. Pharmaceutical care: an introduction. Kalamazoo, MI: The Upjohn Company, 1992.
4. Schommer JC, Cable GL. Current status of pharmaceutical care practice: strategies for education. Am J Pharm Ed 1996;60:36-42.
5. Hatoum HT, Catizone C, Hutchinson RA, Purohit A. An eleven-year review of the pharmacy literature: documentation of the value and acceptance of clinical pharmacy. Drug Intell Clin Pharm 1986;20:33-48.
6. Kozma CM, Reeder CE, Schulz RM. Economic, clinical, and humanistic outcomes: a planning model for pharmacoeconomic research. Clin Ther l993;15:1121-32.
7. Rupp MT. Evaluation of prescribing errors and pharmacist interventions in community practice: an estimate of 'value added.' Am Pharm 1988; NS28(12):22-6.
8. Rupp MT. Value of community pharmacists' interventions to correct prescribing errors. Ann Pharmacother 1992;26:1580-4.
9. Fincham J, Hospodka R, Scott D. The true value of pharmacist care. NARD J 1995;117(3):29-31.
10. Evans RL, Kirk RF, Walker PW, Rosenbluth SA, McDonald J. Medication maintenance of mentally ill patients by a pharmacist in a community setting. Am J Hosp Pharm 1976;33:635-8.
11. Einarson TR, Bootman JL, McGhan WF, Larson LN, Gardner ME, Donohue M. Establishment and evaluation of a serum cholesterol monitoring service in a community pharmacy. Drug Intell Clin Pharm 1988; 22:45-8.
12. Ibrahim OM, Catania PN, Mergener MA, Supernaw RB. Outcome of cholesterol screening in a community pharmacy. DICP Ann Pharmacother 1990;24:817-21.
13. Dobie RL 3rd, Rascati KL. Documenting the value of pharmacist interventions. Am Pharm 1994;NS34(5):50-4.
14. Rupp MT, McCallian DJ, Sheth KK. Developing and marketing a community-based asthma management program. J Am Pharm Assoc 1997; NS37:694-9.
15. Shibley MC, Pugh CB. Implementation of pharmaceutical care services for patients with hyperlipidemias by independent community pharmacy practitioners. Ann Pharmacother 1997;31:713-9.
16. Bluml BM, McKenney JM, Cziraky MJ, Elswick RK Jr. Interim report from project IMPACT: hyperlipidemia. J Am Pharm Assoc 1998;38: 529-34.
17. Clinite JC, Kabat HF. Improving patient compliance. J Am Pharm Assoc 1976;NS16:74-6,85.
18. Slama PJ, Gurwich EL. Effect of pharmacist consultation on medication compliance. Contemp Pharm Pract 1978;1:71-7.
19. Gotsch AR, Liguori S. Knowledge, attitude, and compliance dimensions of antibiotic therapy with PPIs: a community pharmacy-based study. Med Care 1982;20:581-93.
20. Mackowiak JI, Gagnon JP. Expectations for ambulatory services in traditional and office-practice pharmacies. Am J Hosp Pharm 1984;41:1140-6.
21. Kimberlin CL, Berardo DH. A comparison of patient education methods used in community pharmacies. J Pharm Mark Manage 1987;1(4):75-94.
22. Lachman BG. Increasing patient compliance through tracking systems. Calif Pharm 1987;35(3):54-8.
23. Munroe WP, Kunz K, Dalmady-Israel C, Potter L, Schonfeld WH. Economic evaluation of pharmacist involvement in disease management in a community pharmacy setting. Clin Ther 1997;19:113-23.
24. McKenney JM, Slining JM, Henderson HR. Devins D, Barr M. The effect of clinical pharmacy services on patients with essential hypertension. Circulation 1973;48:1104-11.
25. McKenney JM, Brown DE, Necsary R, Reavis HL. Effect of pharmacist drug monitoring and patient education on hypertensive patients. Contemp Pharm Pract 1978;1(2):50-6.
26. McBean BJ, Blackburn JL. An evaluation of four methods of pharmacist-conducted patient education. Can Pharm J 1982;115:167-72.
27. Park JJ, Kelly P, Carter BL, Burgess PP. Comprehensive pharmaceutical care in the chain setting. J Am Pharm Assoc 1996;NS36:443-51.
28. Gurwich EL, Swanson LN. Clinical pharmacy practice in outpatient clinic. J Am Pharm Assoc 1975;NS15:392-9.
29. Schilling KW. Pharmacy program for monitoring diabetic patients. Am J Hosp Pharm 1977;34:1242-5.
30. Brown DJ, Ellsworth A, Taylor JW. Identification of potentially noncompliant patients with a mailed medication refill reminder system. Contemp Pharm Pract 1980;3:244-8.
31. Swenson JP. Training patients to administer intravenous antibiotics at home. Am J Hosp Pharm 1981;38:1480-3.
32. Spruill WJ, Cooper JW, Taylor WJ. Pharmacist-coordinated pneumonia and influenza vaccination program. Am J Hosp Pharm 1982;39:1904-6.
33. Scrivens JJ Jr, Magalian P, Crozier GA. Cost-effective clinical pharmacy services in a veterans administration drop-in clinic. Am J Hosp Pharm 1983;40:1952-3.
34. Conte RR, Kehoe WA, Neilson N, Lodhia H. Nine-year experience with a pharmacist-managed anticoagulation clinic. Am J Hosp Pharm 1986; 43:2460-4.
35. Koecheler JA, Sfier TL, Wilson B. Outcome-focused counseling program for quality assurance in ambulatory care. Am J Hosp Pharm 1990; 47:2020-2.
36. Hatoum HT, Witte KW, Hutchinson RA. Patient care contributions of clinical pharmacists in four ambulatory care clinics. Hosp Pharm 1992; 27:203-6,208-9.
37. Lobas NH, Lepinski PW, Abramowitz PW. Effects of pharmaceutical care on medication cost and quality of patient care in an ambulatory-care clinic. Am J Hosp Pharm 1992;49:1681-8.
38. Radley AS, Hall J. The establishment and evaluation of a pharmacist-developed anticoagulant clinic. Pharm J 1994;252:91-2.
39. Macgregor SH, Hamley JG, Dunbar JA, Dodd TR, Cromarty JA. Evaluation of a primary care anticoagulant clinic managed by a pharmacist. BMJ 1996;312:560.
40. Waddell JA, Solimando DA Jr, Strickland WR, Smith BD, Wray MK. Pharmacy staff interventions in a medical center hematology-oncology service. J Am Pharm Assoc 1998;38:451-6.
41. Garabedian-Ruffalo SM, Gray DR, Sax MJ, Ruffalo RL. Retrospective evaluation of a pharmacist-managed warfarin anticoagulation clinic. Am J Hosp Pharm 1985;42:304-8.
42. Morse GD, Douglas JB, Upton JH, Rodgers S, Gal P. Effect of pharmacist intervention on control of resistant hypertension. Am J Hosp Pharm 1986;43:905-9.
43. loannides-Demos LL, Horne MK, Tong N, Wodak J, Harrison PM, McNeil JJ, et al. Impact of a pharmacokinetics consultation service on clinical outcomes in an ambulatory-care epilepsy clinic. Am J Hosp Pharm 1988;45:1549-51.
44. Haxby DG, Weart CW, Goodman BW Jr. Family practice physicians' perceptions of the usefulness of drug therapy recommendations from clinical pharmacists. Am J Hosp Pharm 1988;45:824-7.
45. Phillips SL, Carr-Lopez SM. Impact of a pharmacist on medication discontinuation in a hospital-based geriatric clinic. Am J Hosp Pharm 1990; 47:1075-9.
46. Deady JE, Lepinski PW, Abramowitz PW. Measuring the ability of clinical pharmacists to effect drug therapy changes in a family practice clinicusing prognostic indicators. Hosp Pharm 1991;26:93-7.
47. Borgsdorf LR, Miano JS, Knapp KK. Pharmacist-managed medication review in a managed care system. Am J Hosp Pharm 1994;51:772-7.
48. Pauley TR, Magee MJ, Cury JD. Pharmacist-managed, physician-directed asthma management program reduces emergency department visits. Ann Pharmacother 1995;29:5-9.
49. Radley AS, Hall J, Farrow M, Carey PJ. Evaluation of anticoagulant control in a pharmacist operated anticoagulant clinic. J Clin Pathol 1995; 48:545-7.
50. Libby EA, Laub JJ. Economic and clinical impact of a pharmacy-based antihypertensive replacement program in primary care. Am J Health-Syst Pharm 1997;54:2079-83.
51. Madden EE Jr. Evaluation of outpatient pharmacy patient counseling. J Am Pharm Assoc 1973;NS13:437-43.
52. Lima J, Nazarian L, Charney E, Lahti C. Compliance with short-term antimicrobial therapy: some techniques that help. Pediatrics 1976;57:383-6.
53. Beardsley RS, Johnson CA, Wise G. Privacy as a factor in patient counseling. J Am Pharm Assoc 1977;17:366-8.
54. Rosen CE, Holmes S. Pharmacist's impact on chronic psychiatric outpatients in community mental health. Am J Hosp Pharm 1978;35:704-8.
55. Davis S. Evaluation of pharmacist management of streptococcal throat infections in a health maintenance organization. Am J Hosp Pharm 1978; 35:561-6.
56. Edwards R, Adams DW. Clinical pharmacy services in a pediatric ambulatory care clinic. Drug Intell Clin Pharm 1982;16:939-44.
57. McGhan WF, Stimmel GL, Hall TG, Gilman TM. A comparison of pharmacists and physicians on the quality of prescribing for ambulatory hypertensive patients. Med Care 1983;21:435-44.
58. Cummings DM, Corson M, Seaman JJ. The effect of clinical pharmacy services provided to ambulatory care patients on hospitalization. Am J Pharm 1984;56(2):44-50.
59. Cohen IA, Hutchison TA, Kirking DM, Shue ME. Evaluation of a pharmacist-managed anticoagulation clinic. J Clin Hosp Pharm 1985;10:167-75.
60. Jones RJ, Goldman MP, Rockwood RP, Imhoff TE. Beneficial effect of a pharmacist refill evaluation clinic. Hosp Pharm 1987;22:166-8.
61. De Tullio PL, Corson ME. Effect of pharmacist counseling on ambulatory patients' use of aerosolized bronchodilators. Am J Hosp Pharm 1987; 44:1802-6.
62. Chrischilles EA, Helling DK, Aschoff CR. Effect of clinical pharmacy services on the quality of family practice physician prescribing and medication costs. DICP Ann Pharmacother 1989;23:417-21.
63. Mason JD, Colley CA. Effectiveness of an ambulatory care clinic pharmacist: a controlled trial. Ann Pharmacother 1993;27:555-9.
64. Wilt VM, Gums JG, Ahmed OI, Moore LM. Outcome analysis of a pharmacist-managed anlicoagulation service. Pharmacotherapy 1995;15: 732-9.
65. McKenney JM, Witherspoon JM. The impact of outpatient hospital pharmacists on patients receiving antihypertensive and anticoagulant therapy. Hosp Pharm 1985;20:9-11,15,406.
66. Forstrom MJ, Ried LD, Stergachis AS, Corliss DA. Effect of a clinical pharmacist program on the cost of hypertension treatment in an HMO family practice clinic. DICP Ann Pharmacother 1990;24:304-9.
67. Jones RA, Lopez LM, Beall DG. Cost-effective implementation of clinical pharmacy services in an ambulatory care clinic. Hosp Pharm 1991; 26:778-82.
68. Botha JH, Tyrannes I, Miller R, Wesley AG. Pharmacokinetic consultation program in a pediatric asthma clinic. Am J Hosp Pharm 1992;49: 1936-40.
69. Nichol A, Nichol DW. Medication management in neuropsychiatric disorders. U. S. Pharmacist 1996;21(Sep):69-70,72,74-5.
70. Erickson SR, Slaughter R, Halapy H. Pharmacists' ability to influence outcomes of hypertension therapy. Pharmacotherapy 1997;17:140-7.
71. Konzern SL, Gray DR, Kashyap ML. Effect of pharmaceutical care on optimum colestipol treatment in elderly hypercholesterolemic veterans. Pharmacotherapy 1997;17:576-83.
72. Sharpe TR, Mikeal RL. Patient compliance with antibiotic regimens. Am J Hosp Pharm 1974;31:479-84.
73. Linkewich JA, Catalano RB, Flack HL. The effect of packaging and instruction on outpatient compliance with medication regimens. Drug Intell Clin Pharm 1974;8:10-5.
74. Chubb JM, Winship HW. The pharmacist's role in preventing medication errors made by cardiac and hyperlipoproteinemic outpatients. Drug Intell Clin Pharm 1974;8:430-6.
75. Paulson PT, Bauch R, Paulson ML, Zilz DA. Medication data sheets: an aid to patient education. Drug Intell Clin Pharm 1976;10:448-53.
76. Gabriel M, Gagnon JP, Bryan CK. Improved patient compliance through use of a daily drug reminder chart. Am J Public Health 1977;67:968-9.
77. Sczupak CA, Conrad WF. Relationship between patient-oriented pharmaceutical services and therapeutic outcomes of ambulatory patients with diabetes mellitus. Am J Hosp Pharm 1977;34:1238-42.
78. Ludy JA, Gagnon JP, Caiola SM. The patient-pharmacist interaction in two ambulatory settings: its relationship to patient satisfaction and drug misuse. Drug Intell Clin Pharm 1977;11:81-9.
79. Helling DK, Hepler CD, Jones ME. Effect of direct pharmaceutical services on patients' perception of health care quality. Am J Hosp Pharm 1979;36:325-9.
80. Hawkins DW, Fiedler FP, Douglas HL, Eschbach RC. Evaluation of a clinical pharmacist in caring for hypertensive and diabetic patients. Am J Hosp Pharm 1979;36:1321-5.
81. Rehder TL, McCoy LK, Blackwell B, Whitehead W, Robinson A. Improving medication compliance by counseling and special prescription container. Am J Hosp Pharm 1980;37:379-85.
82. Garnett WR, Davis U, McKenney JM, Steiner KC. Effect of telephone follow-up on medication compliance. Am J Hosp Pharm 1981;38:676-9.
83. Martin DC, Mead K. Reducing medication errors in a geriatric population. J Am Geriatr Soc 1982;30:258-60.
84. Bond CA, Monson R. Sustained improvement in drug documentation, compliance, and disease control. A four-year analysis of an ambulatory care model. Arch Intern Med 1984;144:1159-62.
85. Baird TK, Broekemeier RL, Anderson MW. Effectiveness of a computer-supported refill reminder system. Am J Hosp Pharm 1984;41:2395-7.
86. Ascione FJ, Shimp LA. The effectiveness of four education strategies in the elderly. Drug Intell Clin Pharm 1984;18:926-31.
87. Gray DR, Garabedian-Ruffalo SM, Chretien SD. Cost-justification of a clinical pharmacist-managed anticoagulation clinic. Drug Intell Clin Pharm 1985;19:575-80.
88. Simkins CV, Wenzloff NJ. Evaluation of a computerized reminder system in the enhancement of patient medication refill compliance. Drug Intell Clin Pharm 1986;20:799-802.
89. De Tullio PL, Kirking DM, Arslanian C, Olson DE. Compliance measure development and assessment of theophylline therapy in ambulatory patients. J Clin Pharm Ther 1987;12:19-26.
90. Stergachis A, Fors M, Wagner EH, Sims DD, Penna P. Effect of clinical pharmacists on drug prescribing in a primary-care clinic. Am J Hosp Pharm 1987;44:525-9.
91. McKenney JM, Munroe WP, Wright JT Jr. Impact of an electronic medication compliance aid on long-term blood pressure control. J Clin Pharmacol 1992;32:277-83.
92. Skaer TL, Sclar DA, Markowski DJ, Won JK. Effect of value-added utilities on prescription refill compliance and Medicaid health care expenditures: a study of patients with non-insulin-dependent diabetes mellitus. J Clin Pharm Ther 1993;18:295-9.
93. Skaer TL, Sclar DA, Markowski DJ, Won JK. Effect of value-added utilities on prescription refill compliance and health care expenditures for hypertension. J Hum Hypertens 1993;7:515-8.
94. Lipton HL, Bird JA. The impact of clinical pharmacists' consultation on geriatric patients' compliance and medical care use: a randomized controlled trial. Gerontologist 1994;34:307-15.
95. Hanlon JT, Weinberger M, Samsa GP, Schmader KE, Uttech KM, Lewis IK, et al. A randomized, controlled trial of a clinical pharmacist intervention to improve inappropriate prescribing in elderly outpatients with polypharmacy. Am J Med 1996;100:428-37.
96. Solomon DK, Portner TS, Bass GE, Gourley DR, Gourley GA, Holt JM, et al. Clinical and economic outcomes in the hypertension and COPD arms of a multicenter outcomes study. J Am Pharm Assoc 1998;38:574-85.
97. Gourley GA, Portner TS, Gourley DR, Rigolosi EL, Holt JM. Solomon DK, et al. Humanistic outcomes in the hypertension and COPD arms of a multicenter outcomes study. J Am Pharm Assoc 1998;38:586-97.
98. Cowper PA, Weinberger M, Hanlon JT, Landsman PB, Samsa GP, Uttech KM, et al. The cost-effectiveness of a clinical pharmacist intervention among elderly outpatients. Pharmacotherapy 1998;18:327-32.
99. McCombs JS, Liu G, Shi J, Feng W, Cody M, Parker JP, et al. The Kaiser Permanente/USC Patient Consultation Study: change in use and cost of health care services. Am J Health-Syst Pharm 1998;55:2495-9.
100. Cody M, McCombs JS, Parker JP. The Kaiser Permanente/USC Patient Consultation Study: change in quality of life. Am J Health-Syst Pharm 1998;55:2615-20.
101. Johnson KA, Parker JP, McCombs JS, Cody M. The Kaiser Permanente/USC Patient Consultation Study: patient satisfaction with pharmaceutical services. Am J Health-Syst Pharm 1998;55:2621-9.
102. Jang R. General purpose of research designs. Am J Hosp Pharm 1980; 37:398-403.
103. Campbell DT, Stanley JC. Experimental and quasi-experimental designs for research. In: Handbook of Research on Teaching. Boston: Houghton Mifflin Company, 1963.
104. Cook TD, Campbell DT. Quasi-experimentation: design and analysis issues for field settings. Boston: Houghton Mifflin Company, 1979.
105. Odedina FT, Segal R. Behavioral pharmaceutical care scale for measuring pharmacists' activities. Am J Health-Syst Pharm 1996;53:855-65.
106. Odedina FT, Hepler CD, Segal R, Miller D. The Pharmacists' Implementation of Pharmaceutical Care (PIPC) model. Pharm Res 1997;14: 135-44.
107. Gupchup GV, Wolfgang AP, Thomas J 3rd. Development of a scale to measure directive guidance by pharmacists. Ann Pharmacother 1996; 30:1369-75.
108. Bungay KM, Boyer JG, Steinwald AB, Ware JE Jr. Health-related quality-of-life: an overview. In: Bootman JL, Townsend RJ, McGhan WF. Principles of pharmacoeconomics. 2nd ed. Cincinnati: Harvey Whitney Books Co., 1996:128-49.
109. MacKeigan LD, Larson LN. Development and validation of an instrument to measure patient satisfaction with pharmacy services. Med Care 1989;27:522-36.
110. Larson LN, MacKeigan LD. Further validation of an instrument to measure patient satisfaction with pharmacy services. J Pharm Market Manage 1994;8:125-39.
111. Farris K, Johnson J, Steele N. Validation of an instrument to assess patient satisfaction with community pharmacists. In: American Pharmaceutical Association Annual Meeting, Miami, Florida, March 21-25, 1998.